Genome Biologics Company
Genome Biologics identifies novel tissue-specific RNAi therapies targeting the transcriptome of cardiovascular and cardiometabolic disease
Total Funding:
2470000.0
Headquarters:
Hessen, Sachsen-Anhalt, Germany
Employee Number:
11-50
Last Funding Type:
Grant
Technology:
Biotechnology, Genetics, Pharmaceutical, Therapeutics
Last Funding Date:
2018-09-01
Investors Number:
1.0
Founded Date:
2017-01-01
Industry:
Early Drug Development